Dimethylformamide → 8-Amino-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one

HRID 1687235Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1687235
[N+:1]([C:4]1[CH:15]=[CH:14][C:7]2[C:8](=[O:13])[NH:9][CH2:10][CH2:11][O:12][C:6]=2[CH:5]=1)([O-])=O.CN(C=O)C>[Pd].C(O)C>[NH2:1][C:4]1[CH:15]=[CH:14][C:7]2[C:8](=[O:13])[NH:9][CH2:10][CH2:11][O:12][C:6]=2[CH:5]=1

Komponenten

5

Edukt 2

HCID 6228DimethylformamideHCID 578537818-nitro-3,4-dihydro-2H-1,4-benzoxazepin-5-one

Produkt 1

HCID 578538478-Amino-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-oneAusbeute 35,1 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 23938PalladiumKatalysatorHCID 702EthanolLösungsmittel

Versuchsvorschrift

A solution of 8-nitro-3,4-dihydro-2H-benzo[f][1,4]oxazepin-5-one (0.23 g, 0.00096 mol), 10% palladium on carbon (0.02 g), DMF (10 mL), and ethanol (30 mL) was hydrogenated for 3 days. Filtration and evaporation gave an oil which was chromatographed on Al2O3 to give 8-amino-3,4-dihydro-2H-benzo[f][1,4]oxazepin-5-one (0.06 g, 35%) as a tan solid. MP: 151-2° C.; 1H-NMR (DMSO-d6) δ 7.77 (s, 1H), 7.54-6 (d, 1H), 6.25-7 (d, 1H), 6.05 (s, 1H), 5.63 (s, 2H), 4.17-9 (m, 2H), 3.25-8 (m, 2H); LC/MS (ESI+): 179 (M+H).

Aufarbeitung

  1. filtrationFiltration and evaporation
  2. customgave an oil which
  3. customwas chromatographed on Al2O3

Quellen und Nachweise

ORD-Eintrag
ord-54cdfb43d4f34823be5d79251c55db2c
Quelldatensatz
uspto-grants-2012_04
Patentnummer
US08148391B2

Notizen zur Reaktion

Wird geladen…